Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

News > France & Monaco

Please find below news from France and Monaco as well as about organisations from these countries.

Total search results: 1485 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Adocia S.A.. (1/18/12). "Press Release: Within the Framework of Its Planned IPO on the Regulated Market of NYSE Euronext in Paris, Adocia Announces the Registration of Its »Document de Base« by the Autorité des Marchés Financiers [Not for US, CA, AU, IT 2012-01-18
Publicis Groupe S.A.. (1/18/12). "Press Release: Publicis Groupe Acquires Mediagong, One of France’s Most Innovative Digital Agencis. Leo Burnett France Will Benefit from Startup’s Digital Smarts". Paris. 2012-01-18
Polyplus-transfection S.A.. (1/18/12). "Press Release: Polyplus-transfection Launches the Next Generation PEI Transfection Reagent for Bioproduction. PEIpro Further Expands an Already Rich Catalogue of Innovative Reagents". Strasbourg. 2012-01-18
Vivalis S.A.. (1/17/12). "Press Release: Vivalis and Sanofi Pasteur Extend Their 2010 Collaboration and License Contract with a New Human Monoclonal Antibody Discovery Target against a New Infectious Disease". Nantes, Lyon & Toyama. 2012-01-17
Novalix S.A.S.. (1/12/12). "Press Release: Novalix Enters into Multi-target Integrated Drug Discovery Collaboration with Teijin Pharma". Strasbourg. 2012-01-12
Cellectis S.A.. (1/9/12). "Press Release: Cellectis Launches a Partnership with Total for Exploratory Research into Microalgae-based Substitutes for Oil Products". Paris. 2012-01-09
Transgene S.A.. (12/21/11). "Press Release: Transgene and Jennerex Announce First Patient Treated in Phase 2a Clinical Trial of JX594/TG6006 in Colorectal Cancer Patients. Product to Be Used as Neoadjuvant Therapy to Patients Undergoing Surgery". Strasbo 2011-12-21
Genopharm. (12/20/11). "Press Release: Suspension of Genopharm and Alkopharm Laboratories. AFSSAPS Keep Going Administratively at Two Laboratories to Avoid Going Back on a Decision, Seriously Striking a Blow at the Public Health". 2011-12-20
Hybrigenics S.A.. (12/19/11). "Press Release: Hybrigenics Completes Enrolment of Its Phase II Clinical Trial of Inecalcitol in Psoriasis. Sixty Patients Have Successfully Been Enrolled in Six Weeks". Paris. 2011-12-19
Sanofi S.A.. (12/19/11). "Press Release: Sanofi Completes Divestiture of Dermik Dermatology Unit to Valeant Pharmaceuticals International, Inc.". Paris. 2011-12-19
Transgene S.A.. (12/16/11). "Press Release: Transgene and the French League against Cancer Enter Partnership to Accelerate Research and Development of New Anticancer Biotherapies". Strasbourg. 2011-12-16
Crédit Agricole S.A.. (12/16/11). "Press Release: Crédit Agricole S.A. and Coller Capital Announce Agreement for the Sale of Crédit Agricole Private Equity". Montrouge. 2011-12-16
Trophos S.A.. (12/13/11). "Press Release: Trophos Announces Results of Phase 3 Study of Olesoxime in Amyotrophic Lateral Sclerosis". Marseille. 2011-12-13
Cytoo S.A.. (12/12/11). "Press Release: Cytoo, Cenix BioScience and Academic Collaborators Bioquant, EPFL and FTMC Receive a 4 M€ EU FP7 Grant to Launch MEHTRICS Consortium". 2011-12-12
Cellectis S.A.. (12/8/11). "Press Release: Cellectis Bioresearch and Syngene Announce Partnership on the Development of Customized Cell Lines". Paris & Bangalore. 2011-12-08
Cellectis S.A.. (12/5/11). "Press Release: Cellectis Signs a License Agreement Under Patents Covering Uses of Homologous Recombination with Global Pharmaceutical Company". Paris. 2011-12-05
EBD Group. (12/1/11). "Press Release: EuroMedtech 2012 Looks to Set New Benchmark for Productive Partnering". Zurich & Grenoble. 2011-12-01
ComplexINC project. (12/1/11). "Press Release: Launch of New EU-funded Project – ComplexINC. It’s an SME-targeted Collaborative Project in FP7 Regarding New Technologies and Production Tools for Complex Protein Biologics". 2011-12-01
Ipsen S.A.. (11/28/11). "Press Release: Ipsen’s Partner Inspiration Biopharmaceuticals Announces the Initiation of the Second Phase III Pivotal Clinical Study of OBI-1 in Congenital Hemophilia A with Inhibitors". Paris. 2011-11-28
Cerenis Therapeutics S.A.. (11/22/11). "Press Release: Cerenis Appoints John F. Paolini as Chief Medical Officer. Internationally Recognized Expert Brings over 15 Years of Experience in Drug Development and Commercialisation to Treat Cardiovascular Disea 2011-11-22
Cerenis Therapeutics S.A.. (11/22/11). "Press Release: The Board of Cerenis Appoints Dr. Richard C. Pasternak as Non Executive Director. Internationally Recognized Expert Brings over 30 Years of Experience in the Field of Cardiovascular Disease". Toulous 2011-11-22
Cytoo S.A.. (11/21/11). "Press Release: Cytoo Raises 10 M$ (7M€) in Series C Round". Grenoble. 2011-11-21
Hybrigenics S.A.. (11/21/11). "Press Release: Hybrigenics Starts Phase II Clinical Trial of Inecalcitol in Psoriasis. Twenty Patients Have Already Been Enrolled in the First Two Weeks of the Study". Paris. 2011-11-21
Sanofi. (11/10/11). "Press Release: Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia". Paris & Tarrytown, NY. 2011-11-10
Prognomix Inc.. (11/8/11). "Press Release: Servier Enters into a Type 2 Diabetes Partnership with Canadian Firm Prognomix Inc.". Suresnes & Montréal. 2011-11-08
Cellectis S.A.. (11/4/11). "Press Release: Cellectis Announces the Final Completion of the Acquisition of Cellartis and €50 Million Financing Round Reserved for the FSI and Mr. Pierre Bastid". 2011-11-04
Eurofins Scientific. (11/2/11). "Press Release: Eurofins Announces Successful Closing of the Transaction for a Majority Stake in IPL SED Nord and IPL Invest". 2011-11-02
Cellectis S.A.. (11/2/11). "Press Release: Cellectis Shareholders Approve the Acquisition of Cellartis. Cellectis Decides to Raise €50 Million from the FSI and Mr. Pierre Bastid, ant to Grant Free Share Purchase Warrants to All Existing Shareholders". Pa 2011-11-02
Poxel S.A.. (10/26/11). "Press Release: New Clinical Results for an Anti-diabetic Compound in Development at Poxel". 2011-10-26
Cellectis S.A.. (10/24/11). "Press Release: Appointment of Philippe Valachs as Cellectis’ General Secretary". Paris. 2011-10-24
Sartorius Stedim Biotech S.A.. (10/20/11). "Press Release: New Dimensions in Flexel for Magnetic Mixers. Sartorius Stedim Biotech Presents 1,500 L and 2,000 L Standard Single-use Mixing Systems for Large Volumes". Göttingen & Aubagne. 2011-10-20
Ipsen S.A.. (10/20/11). "Press Release: Syntaxin and Ipsen Enter into a Strategic Agreement to Develop Novel Botulinum-toxin Therapeutics. Collaboration to Leverage Syntaxin and Ipsen’s Expertise in the Discovery and Development of Botulinum Toxins". Par 2011-10-20
Hybrigenics S.A.. (10/10/11). "Press Release: Hybrigenics and Servier Enter into a License and Research Collaboration Agreement in Oncology and Other Therapeutic Fields. Hybrigenics Will Receive €4 Million over 3 Years". Paris & Suresnes. 2011-10-10
Cellectis S.A.. (10/6/11). "Press Release: Cellectis – 2011 Half-year Results. Recources Strengthened to Support Growth Across All the Group’s Business Lines, with Limited Cash Burn – Important Strategic Moves Implemented". Paris. 2011-10-06
Hybrigenics S.A.. (10/5/11). "Press Release: Hybrigenics Appoints Dr. Alain Munoz to Its Board of Directors". Paris. 2011-10-05
Eurofins Scientific. (10/3/11). "Press Release: Eurofins Signs Definitive Agreement to Acquire Majority Stakes in Institut Pasteur de Lille Subsidiaries, IPL SED Nord and IPL Invest". 2011-10-03
Cellectis S.A.. (10/3/11). "Press Release: Cellectis Issues Statement Regarding Patent Suits on Meganuclease Technology". Paris. 2011-10-03
Novagali Pharma S.A.. (9/28/11). "Press Release: Signing of an Acquisition of a Controlling Interest in Novagali Pharma S.A. by Santen Pharmaceutical Co., Ltd.". Osaka & Évry. 2011-09-28
Cellectis S.A.. (9/26/11). "Press Release: The ETICS Project, Led by Cytoo in Collaboration with Cellectis Bioresearch and the CEA, to Receive €7.6m in Funding from OSEO. A Collaboration to Develop Highly Innovative Kits for Pharmaceutical Research". Par 2011-09-26
Eurofins Scientific. (9/23/11). "Press Release: Eurofins Announces the Inauguration of Its Nantes Laboratory Extension Turning into the Largest Single-site Independent Food Testing Laboratory in the World". 2011-09-23
Cellectis S.A.. (9/15/11). "Press Release: Cellectis Announces Its Upcoming Acquisition of Cellartis, the European Stem Cell Leader, in Conjunction with a Fund Raising Subscribed by the FSI and Pierre Bastid". Paris. 2011-09-15
Cellectis S.A.. (9/7/11). "Press Release: Cellectis Announces a Ten-fold Increase in Nuclease Production Capacity in 2011 – Significantly Expands Potential for Technology Adoption Worldwide". Paris. 2011-09-07
Photonis Holding S.A.S.. (9/7/11). "Press Release: Axa Private Equity Acquires Photonis from Astorg Partners". Paris. 2011-09-07
PX’Therapeutics S.A.. (9/6/11). "Press Release: PX’Therapeutics Licenses Ribovax’s SEBVI Technology for the Development and Manufacturing of Fully Human Monoclonal Antibodies". 2011-09-06
Ipsen S.A.. (8/30/11). "Press Release: Appointments to Ipsen’s Executive Committee. Nathalie Joannes Is Nominated Executive Vice President, General Counsel and Susheel Surpal Is Nominated Executive Vice President, Chief Financial Officer". Paris. 2011-08-30
Novalix S.A.S.. (8/29/11). "Press Release: Novalix and Galapagos Collaborate in Osteroarthritis Discovery Research". Strasbourg. 2011-08-29
Cellectis S.A.. (8/24/11). "Press Release: Cellectis Bioresearch Grants Recombinetics an Exclusive License Agreement for the Use of Targeted Nucleases in Large Livestock". Paris & Minneapolis, MN. 2011-08-24
Transgene S.A.. (8/23/11). "Press Release: Transgene Publishes Phase I Clinical Data of Its HCV Immunotherapy Product in Journal »Gastroenterology« and Announces Future Communication at AASLD". Strasbourg. 2011-08-23
InProcess Instruments Gesellschaft für Prozessanalytik mbH. (8/18/11). "Press Release: InProcess Instruments Presents French Website". 2011-08-18
bioMérieux S.A.. (7/22/11). "Press Release: Completion of the AES Chemunex Group Acquisition and Filing of a Tender Offer for the AES Chemunex Shares". Marcy l’Étoile. 2011-07-22
Cellectis S.A.. (7/20/11). "Press Release: Cellectis Bioresearch and Lonza Achieve Significant Milestone on CHO-K1SV GS Knock-out". Paris & Basel. 2011-07-20
Eurofins Scientific. (7/20/11). "Press Release: Eurofins Signs an Exclusive Agreement with the Fondation Institut Pasteur de Lille towards a Partnership in the Environmental Testing Field". 2011-07-20
bioMérieux S.A.. (7/19/11). "Press Release: bioMérieux Expands Its Infectious Disease Offering with Acquisition of Argene, Specialized in Molecular Diagnostics for Immunocompromised Patients". Marcy l’Étoile. 2011-07-19
Cellectis S.A.. (7/11/11). "Press Release: Dr. Andrew Scharenberg, M.D., to Serve as Chief Scientific Officer for Cellectis Therapeutics". Paris. 2011-07-11
Cellectis S.A.. (7/5/11). "Press Release: TALEN Access by Cellectis Bioresearch Receives »Most Innovative New Service 2011« Award at Life Science Awards". Paris. 2011-07-05
Cellectis S.A.. (6/29/11). "Press Release: Cellectis and Pregenen Sign Collaboration Agreement for the Development of Meganucleases". Paris & Seattle, WA. 2011-06-29
Cellectis S.A.. (6/27/11). "Press Release: André Choulika to Serve as both Chairman and CEO of Cellectis". Paris. 2011-06-27
Sedere. (6/27/11). "Press Release: Product. Release of the New Sedex LT-ELSD Model 90LT". 2011-06-27
Roche. (6/23/11). "Press Release: Roche Sets Up R&D Institute in France to Foster Collaborative Translational Research. Focus on Creation and Expansion of Strategic Partnerships with Leading French Academic Centers". Basel. 2011-06-23
bioMérieux S.A.. (6/22/11). "Press Release: bioMérieux Launches Groundbreaking Salmonella Detection Technology to Improve Food Safety". Marcy l’Étoile. 2011-06-22
Ipsogen S.A.. (6/15/11). "Press Release: Ipsogen Receives an Offer from Qiagen to Fully Acquire Ipsogen and Enters into Exclusive Negotiations". Marseille. 2011-06-15
Ipsen S.A.. (6/9/11). "Press Release: Increase Focus, Invest to Grow, Leverage Footprint [Ipsen Strategy Day]". Paris. 2011-06-09
Ipsen S.A.. (6/9/11). "Press Release: Strategy Day. Presentation". Paris. 2011-06-09
Ipsogen S.A.. (6/7/11). "Press Release: EHA 2011. Ipsogen to Present Its First Multicentre Study on the IS-MMR BCR-ABL Assay". Marseille. 2011-06-07
Cellectis S.A.. (6/6/11). "Press Release: Cellectis and VitamFero Collaborate to Develop Vaccines against Parasitic Infection". Paris & Evry. 2011-06-06
Ipsogen S.A.. (5/30/11). "Press Release: Ipsogen to Present Two Studies on the Genomic Grade Test at ASCO 2011 in Chicago, Ill, USA". Marseille. 2011-05-30
bioMérieux S.A.. (5/19/11). "Press Release: bioMérieux Becomes the World Leader in Food Testing with AES Laboratoire Acquisition". Marcy l’Étoile. 2011-05-19
Cellectis S.A.. (5/18/11). "Press Release: Cellectis Bioresearch Appoints Wako as Exclusive Distributor of Its genome Customization Solutions in Japan. Collaboration Includes Distribution of Recently Launched TALEN Access". Paris & Osaka. 2011-05-18
Advanced Chemistry Development, Inc. (ACD/Labs). (5/17/11). "Press Release: LABERCA, France’s National Reference Laboratory for Food Residues and Contaminants, to Employ ACD/Labs MS Products". Toronto. 2011-05-17
Sanofi S.A.. (5/16/11). "Press Release: Sanofi and Glenmark Pharmaceuticals Sign License Agreement on Novel Monoclonal Antibody for Crohn’s Disease and Other Chronic Autoimmune Disorders". Paris. 2011-05-16
Polyplus-transfection S.A.. (5/11/11). "Press Release: Polyplus-transfection and ExcellGene Enter into a Supply Agreement for PEI-based Transfection Reagents". Strasbourg. 2011-05-11
Santhera Pharmaceuticals. (5/9/11). "Press Release: Santhera Presents Data from 2-year Open-label Intervention Study with Catena in Duchenne Muscular Dystrophy at the Myology 2011 Conference". Liestal. 2011-05-09
Aureus Sciences S.A.. (5/9/11). "Press Release: Aureus Pharma Changes Name to Aureus Sciences and Launches a New Life Science Applications Portal". 2011-05-09
Sanofi S.A.. (5/6/11). "Press Release: Combined General Shareholder Meeting of May 6, 2011. »Sanofi-Aventis« Becomes »Sanofi«". Paris. 2011-05-06
bioMérieux S.A.. (5/5/11). "Press Release: bioMérieux and Labor Berlin (Charité Vivantes GmbH) to Establish Center of Excellence in Laboratory Diagnostics". Berlin & Marcy l’Etoile. 2011-05-05
Ipsogen S.A.. (5/2/11). "Press Release: Ipsogen to Present a Study on Genomic Grade in Lobular Carcinoma at the 3rd IMPAKT Breast Conference in Brussels, Belgium". Marseille. 2011-05-02
Transgene S.A.. (4/18/11). "Press Release: Transgene, ChronTech Pharma and Inovio Pharmaceuticals to Collaborate on Heterologous Prime-boost Therapeutic Vaccination against Hepatitis C. Phase I Study to Access Safety and Immunogenicity". Illkirch. 2011-04-18
Ipsen S.A.. (4/18/11). "Press Release: Active Biotech and Ipsen Enter into a Broad Partnership for the Co-development and Commercialization of TASQ in Uro-oncology". Lund & Paris. 2011-04-18
bioMérieux S.A.. (4/12/11). "Press Release: bioMérieux Achieves 100th PREVI Isola Milestone, Installing Its Automated Plate Streaker at Grady Health System". Marcy l’Étoile. 2011-04-12
Ipsogen S.A.. (4/4/11). "Press Release: Ipsogen and Sysmex Establish a Distribution Agreement for the Japanese Market". Marseille. 2011-04-04
Transgene S.A.. (3/31/11). "Press Release: Transgene Announces Completion of Enrolment in HCVac (Phase II Trial) of TG4040 for the Treatment of Chronic Hepatitis C". Illkirch. 2011-03-31
PathoQuest S.A.S.. (3/29/11). "Press Release: French Pathogens Discovery Biotechnology Start-up, PathoQuest SAS, Raises 2m€ with Kurma BioFund in Its First Round of Financing". Paris. 2011-03-29
Ipsogen S.A.. (3/21/11). "Press Release: 2010 Annual Results. Continuing Growth in Sales over the Year (+24%) and Significant Acceleration during the Second Half of 2010 – Greater Control of Operating Expenses". Marseille. 2011-03-21
Transgene S.A.. (3/16/11). "Press Release: Transgene Reports Full Year 2010 Results". Illkirch. 2011-03-16
bioMérieux S.A.. (3/8/11). "Press Release: bioMérieux – 2010 Financial Results". Marcy l’Étoile. 2011-03-08
Cellectis S.A.. (2/28/11). "Press Release: Cellectis Bioresearch Makes Genome Engineering Affordable for All Users". Paris. 2011-02-28
Ipsogen S.A.. (2/16/11). "Press Release: Revenue for the Year 2010 – 8.37M€ (+24%), Acceleration of Sales During the Second Half of 2010 and a Steady Growth in Consolidated Revenue Over the Year". Marseille. 2011-02-16
Ipsogen S.A.. (2/1/11). "Press Release: Ipsogen and Bio-Reference Laboratories Settle Lawsuit". Marseille. 2011-02-01
Cellectis S.A.. (1/20/11). "Press Release: Cellectis Acquires Exclusive License to TAL Effector Patents from University of Minnesota". Paris. 2011-01-20
bioMérieux S.A.. (1/19/11). "Press Release: bioMérieux – 2010 Business Review". Marcy l’Étoile. 2011-01-19
Cerep S.A.. (1/18/11). "Press Release: Cerep to Reorganize Its Operations in France". Paris. 2011-01-18
Ipsogen S.A.. (1/17/11). "Press Release: Ipsogen Acquires a License from Stanford University of LNK Mutations". Marseille. 2011-01-17
Domain Therapeutics S.A.. (1/17/11). "Press Release: Domain Therapeutics and Merck Serono Announce an Agreement to Develop Drugs for Parkinson’s Disease. Merck Serono to Develop Domain Therapeutics’ mGluR4 Allosteric Modulators". Strasbourg. 2011-01-17
Medigene AG. (1/13/11). "Press Release: MediGene Concludes an Agreement with Laboratoires Expanscience for the Commercialization of Veregen in France". Martinsried. 2011-01-13
Polyplus-transfection S.A.. (1/10/11). "Press Release: Polyplus-transfection Raises EUR 2.5 Million in Latest Funding Round". Strasbourg. 2011-01-10
bioMérieux S.A.. (1/4/11). "Press Release: bioMérieux Expands Customer Services Offer, Appointing James P. Whelan as Executive Vice President, Commercial Services". Marcy l’Étoile. 2011-01-04
Ipsogen S.A.. (12/13/10). "Press Release: Ipsogen Calibrates Its BCR-ABL Assays to the International Scale, a New Progress in Chronic Myeloid Leukemia Management". Marseille. 2010-12-13
Ipsogen S.A.. (12/7/10). "Press Release: Three New Studies on Genomic Grade at 33rd Annual San Antonio Breast Cancer Symposium". Marseille. 2010-12-07
Kurma Partners. (12/6/10). "Press Release: Meiogenix SAS, a French Genomic Start-up Company, Raises 1.2m€ from Investors". 2010-12-06
Bruker Corporation. (12/2/10). "Press Release: Public Hospital Network of Paris (Assistance Publique Hôpitaux de Paris) Has Selected Bruker’s IVD MALDI Biotyper for MALDI-TOF-based Microbial Identification". Paris. 2010-12-02
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top